Breaking News Instant updates and real-time market news.

PRVB

Provention Bio

$6.09 /

-0.48 (-7.31%)

07:09
10/22/19
10/22
07:09
10/22/19
07:09

Provention Bio announces results from Phase 2a PRINCE clinical trial

Provention Bio announced top-line results from its randomized, placebo-controlled Phase 2a PRINCE clinical trial evaluating twice-daily PRV-6527, an oral Colony Stimulating Factor-1 Receptor, or CSF-1R, small molecule inhibitor. The PRINCE study enrolled 93 moderate-to-severe Crohn's disease patients who were either naive to biologic therapy, ~70%, or who had previously failed at least one biologic drug, ~30%. The primary efficacy endpoint of the study was the change in the Crohn's Disease Activity Index, or CDAI, score at week 12. While PRV-6527 demonstrated a substantial improvement in this symptom driven score at week 12, it did not differentiate from placebo. This high placebo response is deemed to be related to the background medication used, ~85%, in the study's predominantly biologic-naive population. RV-6527 was associated with improvements in several key secondary objective endpoints in the steroid-free population, including mucosal endoscopy and tissue histology. PRV-6527 was found to be generally safe and well tolerated, with no drug-related serious adverse events.

PRVB Provention Bio
$6.09 /

-0.48 (-7.31%)

08/05/19 SVB Leerink
Provention Bio price target raised to $35 from $17 at SVB Leerink
06/10/19 Chardan
Provention Bio initiated with a Buy at Chardan
02/22/19 SVB Leerink
Provention Bio initiated with an Outperform at SVB Leerink
01/18/19 H.C. Wainwright
Provention Bio initiated with a Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
Equitrans Midstream sees Q3 net income $125M-$145M » 06:40
08/04/20
08/04
06:40
08/04/20
06:40
ETRN

Equitrans Midstream

$9.75 /

+0.39 (+4.17%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

07/14/20 JPMorgan
Equitrans Midstream initiated with a Neutral at JPMorgan
05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/19/20 RBC Capital
EQT Midstream Partners price target raised to $21 from $15 at RBC Capital
04/27/20 Wells Fargo
Equitrans Midstream double upgraded to Overweight at Wells Fargo
ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

Periodicals
Tesla suspends launch of ESS products in Korea, Korea Times reports » 06:39
08/04/20
08/04
06:39
08/04/20
06:39
TSLA

Tesla

$1,485.21 /

+54.27 (+3.79%)

Tesla has cancelled its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
07/28/20
Fly Intel: Top five analyst downgrades
07/28/20 Bernstein
Bernstein's Sacconaghi downgrades Tesla to sell on 'mind-boggling' valuation
07/28/20 Bernstein
Tesla downgraded to Underperform from Market Perform at Bernstein
TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

  • 14
    Feb
TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

TSLA Tesla
$1,485.21 /

+54.27 (+3.79%)

Earnings
EnPro sees FY20 revenue down 15%-25% y/y, consensus $984.77M » 06:39
08/04/20
08/04
06:39
08/04/20
06:39
NPO

EnPro

$48.20 /

+0.55 (+1.15%)

"Based on our strong…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NPO EnPro
$48.20 /

+0.55 (+1.15%)

NPO EnPro
$48.20 /

+0.55 (+1.15%)

Downgrade
Recordati downgraded to Hold from Buy at Jefferies » 06:39
08/04/20
08/04
06:39
08/04/20
06:39
RCDTF

Recordati

$0.00 /

+ (+0.00%)

Jefferies analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCDTF Recordati
$0.00 /

+ (+0.00%)

07/31/20 Kepler Cheuvreux
Recordati downgraded to Hold from Buy at Kepler Cheuvreux
Earnings
Equitrans Midstream reports Q2 adjusted EPS 22c, consensus 37c » 06:38
08/04/20
08/04
06:38
08/04/20
06:38
ETRN

Equitrans Midstream

$9.75 /

+0.39 (+4.17%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

07/14/20 JPMorgan
Equitrans Midstream initiated with a Neutral at JPMorgan
05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/19/20 RBC Capital
EQT Midstream Partners price target raised to $21 from $15 at RBC Capital
04/27/20 Wells Fargo
Equitrans Midstream double upgraded to Overweight at Wells Fargo
ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

ETRN Equitrans Midstream
$9.75 /

+0.39 (+4.17%)

Recommendations
Cloudflare price target raised to $48 from $29 at RBC Capital » 06:38
08/04/20
08/04
06:38
08/04/20
06:38
NET

Cloudflare

$42.56 /

+0.97 (+2.33%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

07/30/20 Oppenheimer
Cloudflare price target raised to $55 from $35 at Oppenheimer
07/30/20 Baird
Cloudflare price target raised to $45 from $30 at Baird
07/28/20 Jefferies
Cloudflare upgraded to Buy from Hold at Jefferies
07/22/20 Needham
Cloudflare price target raised to $47 from $38 at Needham
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

  • 13
    Sep
NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

NET Cloudflare
$42.56 /

+0.97 (+2.33%)

Earnings
Sony sees FY21 net income Y510B, sales and operating revenue Y8.3T » 06:38
08/04/20
08/04
06:38
08/04/20
06:38
SNE

Sony

$81.29 /

+3.38 (+4.34%)

Sees FY operating income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Earnings
EnPro reports Q2 adjusted EPS 54c, consensus 8c » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
NPO

EnPro

$48.20 /

+0.55 (+1.15%)

Reports Q2 revenue $247M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NPO EnPro
$48.20 /

+0.55 (+1.15%)

NPO EnPro
$48.20 /

+0.55 (+1.15%)

Recommendations
FirstEnergy price target lowered to $28.50 from $45 at Mizuho » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
FE

FirstEnergy

$29.19 /

+0.2 (+0.69%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

07/28/20 Morgan Stanley
FirstEnergy has 'overshot even bearish outcomes' in Ohio, says Morgan Stanley
07/22/20 Argus
FirstEnergy downgraded to Hold on bribery scandal at Argus
07/22/20 Argus
FirstEnergy downgraded to Hold from Buy at Argus
07/22/20 Barclays
FirstEnergy downgraded to Equal Weight from Overweight at Barclays
FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

FE FirstEnergy
$29.19 /

+0.2 (+0.69%)

Hot Stocks
Sony to repurchase Y100B of its own shares from Aug. 5 to March 31, 2021  06:37
08/04/20
08/04
06:37
08/04/20
06:37
SNE

Sony

$81.29 /

+3.38 (+4.34%)

 
ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Upgrade
Natixis upgraded to Buy from Hold at Jefferies » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
NTXFY

Natixis

$0.00 /

+ (+0.00%)

Jefferies analyst Flora…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTXFY Natixis
$0.00 /

+ (+0.00%)

07/15/20 Jefferies
Jefferies downgrades Natixis to Hold on dividend, CIB concerns
07/15/20 Jefferies
Natixis downgraded to Hold from Buy at Jefferies
Hot Stocks
Option Care Health sees FY20 adjusted EBITDA $200M-$210M » 06:37
08/04/20
08/04
06:37
08/04/20
06:37
OPCH

Option Care Health

$11.85 /

+0.09 (+0.77%)

Sees FY20 free cash flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
05/26/20 Canaccord
Option Care Health management meetings lifts optimism, says Canaccord
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

  • 22
    Jul
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

Hot Stocks
Zimmer Biomet saw incremental improvement in May, June » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Upgrade
Deutsche Bank upgrades McKesson to Buy after 'solid' Q1 beat » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
MCK

McKesson

$159.78 /

+10.22 (+6.83%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

05:24 Today Deutsche Bank
McKesson upgraded to Buy from Hold at Deutsche Bank
07/08/20 Guggenheim
McKesson price target raised to $175 from $168 at Guggenheim
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

MCK McKesson
$159.78 /

+10.22 (+6.83%)

Earnings
Option Care Health reports Q2 EPS (4c), consensus (8c) » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
OPCH

Option Care Health

$11.85 /

+0.09 (+0.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
05/26/20 Canaccord
Option Care Health management meetings lifts optimism, says Canaccord
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

  • 22
    Jul
OPCH Option Care Health
$11.85 /

+0.09 (+0.77%)

Earnings
Sony reports Q1 Y191.09 vs. Y121.78 last year » 06:36
08/04/20
08/04
06:36
08/04/20
06:36
SNE

Sony

$81.29 /

+3.38 (+4.34%)

Reports Q1 revenue Y1.97T…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

SNE Sony
$81.29 /

+3.38 (+4.34%)

Earnings
Bio-Techne reports Q4 adj. EPS $1.00, consensus 75c » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
TECH

Bio-Techne

$279.15 /

+4.49 (+1.63%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
05/27/20 Stifel
Bio-Techne downgraded to Hold from Buy at Stifel
05/14/20 Benchmark
Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy
05/14/20 Benchmark
Bio-Techne initiated with a Buy at Benchmark
TECH Bio-Techne
$279.15 /

+4.49 (+1.63%)

Upgrade
MTU Aero Engines upgraded to Buy from Hold at HSBC » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
MTUAY

MTU Aero Engines

$0.00 /

+ (+0.00%)

HSBC analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTUAY MTU Aero Engines
$0.00 /

+ (+0.00%)

05:30 Today HSBC
MTU Aero Engines upgraded to Buy from Hold at HSBC
07/27/20 JPMorgan
MTU Aero Engines price target raised to EUR 107 from EUR 78 at JPMorgan
07/21/20 Exane BNP Paribas
MTU Aero Engines downgraded to Underperform from Neutral at Exane BNP Paribas
07/14/20 UBS
MTU Aero Engines price target raised to EUR 144 from EUR 128 at UBS
Earnings
Primoris sees FY20 EPS $1.60-$1.80, consensus $1.25  06:35
08/04/20
08/04
06:35
08/04/20
06:35
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

 
ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Earnings
Epizyme reports Q2 EPS (58c), consensus (61c) » 06:35
08/04/20
08/04
06:35
08/04/20
06:35
EPZM

Epizyme

$14.40 /

+0.56 (+4.05%)

Reports Q2 revenue $2.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

06/19/20 Citi
Epizyme should be bought on any confusion over label, at Citi
06/18/20 Jefferies
Jefferies sees broad approval for Epizyme's Taz as 'fundamental positive'
06/02/20 Wedbush
Epizyme removed from Best Ideas List at Wedbush
04/01/20 Oppenheimer
Epizyme downgraded to Perform at Oppenheimer
EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

EPZM Epizyme
$14.40 /

+0.56 (+4.05%)

Earnings
Zimmer Biomet not providing FY20 guidance due to COVID-19 » 06:34
08/04/20
08/04
06:34
08/04/20
06:34
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Zimmer Biomet said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Hot Stocks
Primoris reports total backlog at June 30 of $3.5B  06:34
08/04/20
08/04
06:34
08/04/20
06:34
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

 
ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Upgrade
Reliance Steel upgraded to Buy from Hold at Deutsche Bank » 06:34
08/04/20
08/04
06:34
08/04/20
06:34
RS

Reliance Steel

$101.14 /

+2.81 (+2.86%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

07/29/20 Citi
Reliance Steel price target raised to $115 from $90 at Citi
05/13/20 KeyBanc
Reliance Steel downgraded to Sector Weight from Overweight at KeyBanc
04/24/20 Citi
Reliance Steel price target lowered to $90 from $125 at Citi
03/30/20 Goldman Sachs
Reliance Steel upgraded to Buy from Neutral at Goldman Sachs
RS Reliance Steel
$101.14 /

+2.81 (+2.86%)

Earnings
Primoris reports Q2 EPS 68c, consensus 29c » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
PRIM

Primoris

$16.82 /

+0.83 (+5.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

PRIM Primoris
$16.82 /

+0.83 (+5.19%)

07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
PRIM Primoris
$16.82 /

+0.83 (+5.19%)

Earnings
Zimmer Biomet reports Q2 adj. EPS 5c, consensus (73c) » 06:33
08/04/20
08/04
06:33
08/04/20
06:33
ZBH

Zimmer Biomet

$135.79 /

+0.94 (+0.70%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
05/18/20 JMP Securities
Zimmer Biomet price target lowered to $150 from $175 at JMP Securities
05/12/20 SVB Leerink
Zimmer Biomet price target raised to $136 from $130 at SVB Leerink
05/12/20 Deutsche Bank
Zimmer Biomet price target lowered to $146 from $160 at Deutsche Bank
ZBH Zimmer Biomet
$135.79 /

+0.94 (+0.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.